Klinger Shannon Thyme bought MRNA
March 5, 2026 · Form 4 insider transaction
Klinger Shannon Thyme bought 11,797 shares of Moderna, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,797
Price
N/A
Total value
N/A
InsiderKlinger Shannon Thyme
Role—
CompanyModerna, Inc. (MRNA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 5, 2026
Filing dateMarch 6, 2026
Shares owned after71,486
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.